Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 +3.63%18 Current Ratio is 1.83 as of Mar. 2026, which is 1% above its 10-year median of 1.82. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 121 Medical Distribution companies, Aptus Pharma ranks better than 73.55% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Aptus Pharma's current ratio for the quarter that ended in Mar. 2026 was 1.83.
Aptus Pharma has a current ratio of 1.83. It generally indicates good short-term financial strength.
The historical rank and industry rank for Aptus Pharma's Current Ratio or its related term are showing as below:
BOM:544529'
s Current Ratio Range Over the Past 10 Years
Min: 1.63 Med: 1.82 Max: 2.01
Current: 1.83
During the past 4 years, Aptus Pharma's highest Current Ratio was 2.01. The lowest was 1.63. And the median was 1.82.
BOM:544529's Current Ratio is ranked better than 73.55% of 121
companies
in the Medical Distribution industry
Industry Median: 1.4
vs BOM:544529: 1.83
Aptus Pharma (BOM:544529) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Aptus Pharma Current Ratio Related Terms
Aptus Pharma Current Ratio Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544529 vs MCK, COR, CAH: Current Ratio Comparison
For the Medical Distribution subindustry, Aptus Pharma's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's Current Ratio distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptus Pharma (BOM:544529) has a Current Ratio of 1.83 as of Mar. 2026. This is near median its historical median of 1.82. Over the past decade, Aptus Pharma's Current Ratio has ranged from 1.63 to 2.01. According to the industry distribution chart, Aptus Pharma ranks #32 out of 121 companies in the Medical Distribution industry, placing it in the top 26.4%.
Is Aptus Pharma's Current Ratio too high?
Aptus Pharma's current Current Ratio of 1.83 is near median its 10-year median of 1.82. Over the past 10 years, this metric has ranged from a low of 1.63 to a high of 2.01. The Medical Distribution industry median Current Ratio is 1.40. Aptus Pharma's value of 1.83 is 30.7% above this industry median. Based on the distribution chart, Aptus Pharma ranks #32 out of 121 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Current Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #32 out of 121 companies for Current Ratio. This puts Aptus Pharma in the upper half of its industry. The industry median Current Ratio is 1.40. Aptus Pharma's value of 1.83 is 30.7% above this benchmark. Historically, Aptus Pharma's own Current Ratio has ranged from 1.63 to 2.01 over the past decade. While the company's 10-year median is 1.82 vs. the industry median of 1.40, Aptus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptus Pharma's current Current Ratio of 1.83 is 30.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current Current Ratio is 1.83, which is near median its own 10-year median of 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Current Ratio of 1.83. The current Current Ratio is 1.83, which is near median its 10-year median of 1.82 and 30.7% above the Medical Distribution industry median of 1.40. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Current Ratio is 1.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
